Home

Which medications are in a shortage right now?

We track the U.S. FDA's official drug-shortage list for the medications we cover, and refresh it a few times a day.

A national shortage doesn't mean every pharmacy is out, and a drug not on the list can still be unavailable at the store nearest you. Local stock changes constantly. That's the gap RxFinder fills: we call pharmacies near you to find who actually has it today.

U.S. drug shortages are near record highs

Active drug shortages nationwide hit an all-time high of 323 in early 2024, surpassing the prior record of 320 set in 2014, and the highest since tracking began in 2001. They've eased since but remain historically elevated.

295End of 2022309Mid 2023323Early 2024record high270Early 2025latest

77% of active shortages began in 2022 or later

Active (ongoing) U.S. drug shortages. Source: ASHP / University of Utah Drug Information Service. Figures are the counts reported for each period.

On the current FDA shortage list

  • Adderall IRIn FDA shortage

    Reported short: Tablet · updated Oct 2, 2026

    Find local stock
  • ConcertaIn FDA shortage

    Reported short: Tablet · updated Oct 1, 2026

    Find local stock
  • Generic Amphetamine Salts (IR)In FDA shortage

    Reported short: Tablet · updated Oct 2, 2026

    Find local stock
  • Generic Methylphenidate ERIn FDA shortage

    Reported short: Tablet · updated Oct 1, 2026

    Find local stock
  • SaxendaIn FDA shortage

    Reported short: Injection · updated Sep 22, 2026

    Find local stock
  • VyvanseIn FDA shortage

    Reported short: Capsule · Tablet, Chewable · updated Oct 2, 2026

    Find local stock

Shortage status is sourced from the U.S. FDA drug-shortage database and matched to our medications by active ingredient; it may lag real-world conditions. Local stock information is gathered via automated calls and may be inaccurate or out of date. Always call the pharmacy to confirm before traveling. RxFinder is a stock locator, not a pharmacy, healthcare provider, or medical advice.